000 | 01075 a2200289 4500 | ||
---|---|---|---|
005 | 20250513211941.0 | ||
264 | 0 | _c20000926 | |
008 | 200009s 0 0 eng d | ||
022 | _a0037-1963 | ||
024 | 7 |
_a10.1016/s0037-1963(00)90052-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKuter, D J | |
245 | 0 | 0 |
_aFuture directions with platelet growth factors. _h[electronic resource] |
260 |
_bSeminars in hematology _cApr 2000 |
||
300 |
_a41-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMyelodysplastic Syndromes _xdrug therapy |
650 | 0 | 4 |
_aPlatelet-Derived Growth Factor _xpharmacology |
650 | 0 | 4 |
_aProtein Engineering _xtrends |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
650 | 0 | 4 |
_aThrombopoietin _xchemical synthesis |
773 | 0 |
_tSeminars in hematology _gvol. 37 _gno. 2 Suppl 4 _gp. 41-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0037-1963(00)90052-0 _zAvailable from publisher's website |
999 |
_c10782825 _d10782825 |